Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards

[1]  Lennart Sjöberg,et al.  Ahlstrand E , Persson L , Tidefelt U , Söderquist B. Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy. Eur J Clin Microbiol Infect Dis , 2011 .

[2]  N. Woodford,et al.  Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria. , 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[3]  O. Cars,et al.  Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamases: a Prospective Study with Swedish Volunteers , 2010, Antimicrobial Agents and Chemotherapy.

[4]  N. Woodford,et al.  Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli. , 2009, The Journal of antimicrobial chemotherapy.

[5]  D. Raveh,et al.  Prospective Evaluation of Colonization with Extended-Spectrum β-Lactamase (ESBL)–Producing Enterobacteriaceae Among Patients at Hospital Admission and of Subsequent Colonization with ESBL-Producing Enterobacteriaceae Among Patients During Hospitalization , 2009, Infection Control & Hospital Epidemiology.

[6]  F. Ariey,et al.  CTX-M β-Lactamases in Escherichia coli from Community-acquired Urinary Tract Infections, Cambodia , 2009, Emerging infectious diseases.

[7]  C. Vandenbroucke-Grauls,et al.  Enrichment Broth Improved Detection of Extended-Spectrum-Beta-Lactamase-Producing Bacteria in Throat and Rectal Surveillance Cultures of Samples from Patients in Intensive Care Units , 2009, Journal of Clinical Microbiology.

[8]  D. Church,et al.  Molecular Characteristics of Travel-Related Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from the Calgary Health Region , 2009, Antimicrobial Agents and Chemotherapy.

[9]  D. Church,et al.  Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. , 2008, The Journal of infection.

[10]  A. Oliver,et al.  Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. , 2008, Archives of internal medicine.

[11]  K. Laupland,et al.  Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern , 2008 .

[12]  D. Maki,et al.  Effectiveness of preemptive barrier precautions in controlling nosocomial colonization and infection by methicillin-resistant Staphylococcus aureus in a burn unit. , 2006, American journal of infection control.

[13]  Y. Carmeli,et al.  Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  P. Coll,et al.  Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain. , 2005, The Journal of antimicrobial chemotherapy.

[15]  S. Mitsuhashi,et al.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens , 1983, Infection.

[16]  D. Church,et al.  Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  S. Castelain,et al.  Coexistence of SHV-4- and TEM-24-Producing Enterobacter aerogenes Strains before a Large Outbreak of TEM-24-Producing Strains in a French Hospital , 2001, Journal of Clinical Microbiology.

[18]  J. Lucet,et al.  Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing enterobacteriaceae in a university hospital. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  A. Lesimple,et al.  Epidemiological typing of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital. , 1997, The Journal of hospital infection.

[20]  R. Cluzel,et al.  Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase. , 1987, The Journal of antimicrobial chemotherapy.